The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...

South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

In this Oct. 7, 2019, file photo, a pharmacist displays the HIV prevention drugs Descovy, left and Truvada, right, at a pharmacy in Sacramento, Calif. A proposed federal policy aims to protect older ...

Nursing home patients with HIV tend to be younger. They also typically have more comorbidities than the average patient, and ...

KZN to receive Lenacapavir,new long-acting HIV prevention injection. Minister Motsoaledi confirms rollout to 360 clinics, for ...

For the 2.3 million residents of Lesotho, the announcement of massive cuts to the U.S. aid that sustained much of the small ...

Medications that prevent HIV, shrink tumors and treat seizures were invented with government funding. At research ...